DNA微阵列芯片法检测耐药结核分枝杆菌的临床应用价值研究

doi:10.3969/j.issn.1000-6621.2018.10.011

摘要/Abstract

摘要：

目的评价DNA微阵列芯片法检测结核分枝杆菌及其对异烟肼和利福平耐药的检测效能。方法收集2011年1月至2017年5月间在江苏省灌云县疾病预防控制中心登记的814例涂阳肺结核患者的痰标本。利用传统罗氏培养法及比例法药物敏感性试验(简称“药敏试验”)和DNA微阵列芯片法,同时对患者的痰标本进行结核分枝杆菌检测,并检测其对异烟肼和利福平的耐药情况;分别以传统罗氏培养及比例法药敏试验为标准,评价DNA微阵列芯片法的检测效能。结果 DNA微阵列芯片法对涂阳肺结核患者的结核分枝杆菌检出率为86.1%(701/814),高于传统罗氏培养法的82.4%(671/814),差异有统计学意义(χ ²=6.81,P<0.05)。以传统罗氏培养法为标准,DNA微阵列芯片法检测涂阳患者结核分枝杆菌的敏感度和特异度分别为92.4%(620/671)和43.4%(62/143),Kappa=0.39,阳性预测值和阴性预测值分别为88.4%(620/701)和54.9%(62/113)。以药敏试验为标准,对有完整的异烟肼和利福平耐药检测结果的620例患者进行分析,DNA微阵列芯片法检测初治涂阳患者是否对异烟肼与利福平耐药的敏感度分别为78.7%(37/47)和84.6%(22/26),阳性预测值分别为69.8%(37/53)和73.3%(22/30);检测复治涂阳患者是否对异烟肼与利福平耐药的敏感度分别为71.9%(23/32)和89.3%(25/28),阳性预测值分别为85.2%(23/27)和89.3%(25/28)。结论 DNA微阵列芯片法对结核分枝杆菌的检出率高于传统罗氏培养;对结核分枝杆菌对异烟肼和利福平耐药性检测效果理想,具有较好的应用价值。

关键词: 分枝杆菌, 结核, 结核, 抗多种药物性, 芯片分析技术, 评价研究

Abstract:

Objective To evaluate the performance of DNA microarray chip to detect Mycobacterium tuberculosis (MTB) and determine the susceptibility to isoniazid (INH) and rifampicin (RFP). Methods A total of 814 specimens of sputum smear-positive (SS+) pulmonary tuberculosis cases registered in Guanyun County Center for Disease Control and Prevention between January 2011 and May 2017 were collected. Proportion method using L?wenstein-Jensen culture medium, drug susceptibility testing (DST) and DNA microarray chip were performed to detect MTB and to test the susceptibility to INH and RFP of the sputum specimens. The detection value of DNA microarray chip was assessed by using proportion method and DST as standard, respectively. Results DNA microarray chip showed a significant difference (χ ²=6.81, P<0.05) in the detection of MTB in SS+ cases with a detection rate of 86.1% (701/814), which was higher than that of proportion method (82.4%, 671/814). Taking proportion method as standard, the sensitivity and specificity of DNA microarray chip in detecting MTB were 92.4% (620/671) and 43.4% (62/143), Kappa value was 0.39, and positive predictive value (PPV) and negative predictive value (NPV) were 88.4% (620/701) and 54.9% (62/113), respectively. Taking DST as standard, analysis of 620 patients with complete results of INH- and RFP-resistance showed that the sensitivity of DNA microarray method for detecting INH and RFP resistance in new SS+ cases was 78.7% (37/47) and 84.6% (22/26), and the PPV was 69.8% (37/53) and 73.3% (22/30), respectively. The sensitivity of DNA microarray method for detecting INH and RFP resistance in relapse SS+ cases was 71.9% (23/32) and 89.3% (25/28), and the PPV were 85.2% (23/27) and 89.3% (25/28), respectively. Conclusion Compared with proportion method, the detection rate of DNA microarray chip for MTB is higher. The testing performance of DNA microarray chip to detect INH- and RFP-resistance are sound regarding its high validity and reliability, which may be of great value in prevention and control of tuberculosis.

Key words: Mycobacterium tuberculosis, Tuberculosis, multidrug-resistant, Microchip analytical procedures, Evaluation studies

单永梅,王伟炳,王建美. DNA微阵列芯片法检测耐药结核分枝杆菌的临床应用价值研究[J]. 中国防痨杂志, 2018, 40(10): 1083-1088. doi: 10.3969/j.issn.1000-6621.2018.10.011

Yong-mei SHAN,Wei-bing WANG,Jian-mei WANG. The study of clinical application value of DNA microarray chip in detection of drug-resistant Mycobacterium tubercu-losis[J]. Chinese Journal of Antituberculosis, 2018, 40(10): 1083-1088. doi: 10.3969/j.issn.1000-6621.2018.10.011

图/表 3

表1

图1

表2

参考文献 15

[1]	中华人民共和国卫生部. 全国结核病耐药性基线调查报告(2007—2008年). 北京: 人民卫生出版社, 2010.
[2]	郝宝林, 邢进, 李辉 . DNA微阵列芯片法检测临床痰标本中结核分枝杆菌耐多药突变基因的研究. 医药论坛杂志, 2014,35(7):45-46.
[3]	林翀, 林明冠, 廉芳 , 等. DNA微阵列芯片法检测结核分枝杆菌耐利福平基因的研究. 中国热带医学, 2016,16(2):107-110. doi: 10.13604/j.cnki.46-1064/r.2016.02.03 URL
[4]	刘亚芹, 杨振斌, 冯冬霞 . DNA微阵列芯片法与常规生化法在分枝杆菌菌种鉴定方面的比较. 中国实验诊断学, 2013,17(11):2026-2029.
[5]	刘亚芹, 杨振斌, 冯冬霞 , 等. DNA微阵列芯片法用于检测结核分枝杆菌耐药性的研究. 国际检验医学杂志, 2014,35(14):1910-1913. doi: 10.3969/j.issn.1673-4130.2014.14.040 URL
[6]	钟业腾, 林明冠, 林翀 , 等. DNA微阵列芯片法检测结核分枝杆菌耐异烟肼基因的研究. 中国热带医学, 2017,17(3):270-273. doi: 10.13604/j.cnki.46-1064/r.2017.03.15 URL
[7]	中华人民共和国卫生部. 中国结核病防治规划实施工作指南 (2008 年版). 北京: 中国协和医科大学出版社, 2009.
[8]	管红云, 谭卫国, 杨应周 , 等. 2006—2014年深圳市652例耐多药结核病患者的发现及治疗与管理. 中国防痨杂志, 2017,39(5):518-524. doi: 10.3969/j.issn.1000-6621.2017.05.020 URL
[9]	中国防痨协会基础专业委员会. 结核病诊断实验室检验规程. 北京: 中国教育文化出版社, 2006.
[10]	詹思延 .流行病学. 7版. 北京: 人民卫生出版社, 2012.
[11]	Hu Y, Hoffner S, Jiang W , et al. Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a popu-lation-based study. Int J Tuberc Lung Dis, 2010,14(2):210-216.
[12]	Yang C, Luo T, Shen X , et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a re-trospective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis, 2017,17(3):275-284.
[13]	Cade CE, Dlouhy AC, Medzihradszky KF , et al. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. Protein Sci, 2010,19(3):458-474.
[14]	Pietzka AT, Indra A, Stöger A , et al. Rapid identification of multidrug-resistant Mycobacterium tuberculosis isolates by rpoB gene scanning using high-resolution melting curve PCR analysis. J Antimicrob Chemother, 2009,63(6):1121-1127.
[15]	张立群, 王云霞, 周敏 , 等. 4种不同结核分枝杆菌检测方法对结核病的诊断价值比较. 中华医院感染学杂志, 2010,20(11):1633-1635.